The most serious risk that comes along with treating AMD is getting an infection. We take significant precautions to prevent this from happening which makes the treatment low risk.
Praveen Patel has a lot of experience in treating age-related macular degeneration. He has led research on AMD. When Praveen treats wet AMD, he is often able to stabilise and even improve the patient's vision.
Lydia Chang holds a safety record for Glaucoma Treatments that is better than the national average. To learn more about the precautions Ms Chang takes, read this blog.
My NHS subspecialty expertise is in the subject of glaucoma. This means that I base my outpatient services almost exclusively on assessing patients who may have risk factors for glaucoma or patients that already have a glaucoma diagnosis.
Unlike cataract surgery, where you get a visual result quickly after the operation, some glaucoma treatment results are built up over time and individualised to the patient.
We achieve the best long-term treatment when we start treatment early before significant damage to the light detecting retinal cells (photoreceptors) due to wet AMD.
The two most common misconceptions about macular degeneration are that only one injection will treat AMD and that all forms of AMD are treatable.
I’ve built up experience a considerable amount of expertise over the last ten or 15 years. Not every consultant that you see specialises in AMD treatment to the degree that I do. I do see patients with general problems with their eyes regarding general ophthalmology, but I decided to specialise in wet AMD treatment.